Bacillus subtillis genetically engineered bacterium capable of improving yield of 2, 6-dipicolinic acid and application of bacillus subtillis genetically engineered bacterium

By overexpressing the transcriptional regulator spoA in Bacillus subtilis, the yield of 2,6-pyridine dicarboxylic acid was improved, and the problem of insufficient yield of wild-type strains was solved, which significantly enhanced its resistance to plant pathogens and its prevention and treatment effect.

CN118931809APending Publication Date: 2024-11-12NANTONG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311271988.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-09-28
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

The 2,6-pyridine dicarboxylic acid yield of wild-type Bacillus subtilis 168 is extremely low, which cannot meet the application needs of biological control agents, and its poor colonization ability limits its application in plant disease prevention and control.

Method used

Recombinant strains were constructed to increase their DPA yield during fermentation by inserting the gene sequence of the transcriptional regulator spoOA into the expression plasmid pMA5 and transforming it into Bacillus subtilis.

Benefits of technology

The glucose consumption rate and bacterial growth rate have been improved, the yield of 2,6-pyridine dicarboxylic acid has been significantly improved, the antifungal activity against plant pathogens has been enhanced, and the sweet potato black spot disease has been effectively prevented.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118931809A_ABST
    Figure CN118931809A_ABST
Patent Text Reader

Abstract

The invention discloses a bacillus subtillis genetically engineered bacterium for improving the yield of 2, 6-dipicolinic acid and application of the bacillus subtillis genetically engineered bacterium. The genetically engineered bacterium is obtained by transferring a transcriptional regulation factor spo0A into bacillus subtillis 168, and the nucleotide sequence of the transcriptional regulation factor spo0A is as shown in SEQ ID NO: 1. The invention further discloses a preparation method of the genetically engineered bacterium. The recombinant strain is obtained by overexpressing the endogenous transcription regulation factor spo0A of the bacillus subtillis in a bacillus subtillis 168 strain by using an expression vector constitutive plasmid pMA5, so that the glucose consumption rate, the thallus growth rate and the DPA yield can be improved in the fermentation process.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of molecular biology, and specifically relates to a Bacillus subtilis genetic engineering bacterium with improved 2,6-pyridinedicarboxylic acid production and application thereof. Background Art

[0002] The economic losses caused by plant diseases are huge every year in the world. Global warming causes the ecological niche of pathogens to move to high latitudes, and plant diseases and the losses they cause are becoming more serious. Long-term use of pesticides can make pathogens resistant, and will cause problems such as pesticide residues, environmental pollution, and harm to human health. Green control technology has been proposed and received widespread attention. Compared with biocontrol fungi, biocontrol bacteria are easier to mass produce and genetically modify. Using biocontrol bacteria to control plant fungal diseases has become an important means in the field of biological control. In the field of biocontrol bacteria, Bacillus is one of the most important genera of Gram-positive bacteria, among which Bacillus subtilis is a ubiquitous environmental bacterium. Bacillus subtilis 168 is a model strain with clear genetic information and is easy to carry out molecular modification to synthesize a large number of target products. However, the wild type Bacillus subtilis 168 has poor colonization ability and few known antibacterial metabolites, which limits the application of this strain as a biological control agent.

[0003] Song Xuege and others isolated a new antifungal secondary metabolite, 2,6-pyridinedicarboxylic acid (DPA), from the fermentation broth of Bacillus subtilis 168, which exhibited broad-spectrum antifungal activity against a variety of plant pathogens. As a natural product, DPA is an oxidative degradation product of microorganisms, coenzymes, and alkaloids. It is easily degraded on the surface of plants, leaves no residue, and has good environmental compatibility. However, the DPA production of the wild-type 168 strain is extremely low and cannot meet application requirements. It is urgent to develop effective molecular modification methods to increase the DPA production of the recombinant strain, thereby improving the biocontrol effectiveness of the recombinant strain. Summary of the invention

[0004] One of the purposes of the present invention is to provide a strain of Bacillus subtilis genetically engineered bacteria with improved 2,6-pyridinedicarboxylic acid production. The genetically engineered bacteria is a strain in which the transcriptional regulatory factor spo0A is transferred into Bacillus subtilis ( Bacillus subtilis ) 168 to obtain a genetically engineered bacterium, wherein the nucleotide sequence of the transcriptional regulatory factor spo0A is shown in SEQ ID NO: 1.

[0005] The second object of the present invention is to provide a method for preparing the above-mentioned genetically engineered bacteria, comprising the following steps: Step 1, inserting the gene sequence of the transcriptional regulatory factor spo0A into the expression plasmid to obtain a recombinant plasmid; Step 2, transforming the recombinant plasmid obtained in step 1 into Bacillus subtilis ( Bacillus subtilis )168 obtained.

[0006] Wherein, the expression plasmid described in step 1 is pMA5.

[0007] The third object of the present invention is to provide the use of the above genetically engineered bacteria in the fermentation production of 2,6-pyridinedicarboxylic acid.

[0008] The culture conditions for fermentation using the genetically engineered bacteria are as follows: The strain activation method is as follows: use LB liquid culture medium, culture conditions are 37°C, 200 r / min, pH = 7.0-7.2.

[0009] The seed culture method is as follows: use a 250 mL conical flask containing 50 mL LB medium for seed culture at 37°C, 200 rpm, and culture until OD 600 = 2.0.

[0010] The fermentation culture method is as follows: take 10 mL of seed culture, centrifuge at 8,000 × g, 4°C for 10 min, and then add the collected cells to a 250 mL conical flask containing 100 mL of LB medium for fermentation culture. The culture conditions are 37°C, 200 r / min, and aerobic shaking culture for 72 h.

[0011] The fourth object of the present invention is to provide a product for preventing and controlling sweet potato black spot disease, wherein the active ingredient is obtained by fermenting the above-mentioned genetically engineered bacteria.

[0012] Those skilled in the art can adjust the above-mentioned culture conditions or medium formulations. Beneficial Effects

[0013] Compared with the prior art, the present invention overexpresses the endogenous transcriptional regulatory factor spo0A of Bacillus subtilis in the expression vector constitutive plasmid pMA5 in the Bacillus subtilis 168 strain to obtain a recombinant strain, which can improve the glucose consumption rate, bacterial growth rate and DPA yield during the fermentation process. The molecular operation of the present invention is simple and does not require a long-term evolution process. It is an attempt to improve the DPA fermentation performance of Bacillus subtilis. BRIEF DESCRIPTION OF THE DRAWINGS

[0014] Figure 1 This is the plasmid vector map for overexpression of spo0A. The expression plasmid used is the constitutive plasmid pMA5.

[0015] Figure 2 The glucose concentration and OD of the control strain (CON) and the overexpression strain (SPO0A) during the fermentation process in Example 1 are 600And the curve of 2,6-pyridinedicarboxylic acid (DPA) concentration changing with time. Where: a is the residual glucose concentration in the fermentation broth; b is the OD reflecting the growth of the bacteria 600 ; c is the concentration of DPA in the fermentation broth.

[0016] Figure 3 This is a diagram showing the pathological changes of sweet potatoes caused by the sweet potato long beak fungus after spraying different liquids on the sweet potato pieces inoculated with the sweet potato long beak fungus in Example 2. 2 O (control) sweet potato lesion condition; b is spraying control strain (CON) bacterial resuspension (in ddH 2 The lesion of sweet potato after spraying the heavy suspension of the overexpression strain (SPO0A) (in ddH 2 Figure 3. Pathological changes of sweet potato after (O resuspension). Implementation

[0017] The preferred embodiments of the present invention will be described in detail below in conjunction with examples. It should be understood that the following examples are provided only for the purpose of illustration and are not intended to limit the scope of the present invention. Those skilled in the art may make various modifications and substitutions to the present invention without departing from the purpose and spirit of the present invention.

[0018] Unless otherwise specified, the experimental methods used in the following examples are conventional methods.

[0019] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources. Example 1

[0020] Construction and cultivation of recombinant strains of Bacillus subtilis The constitutive plasmid pMA5 was used as a vector to overexpress the transcriptional regulatory factor spo0A in wild-type Bacillus subtilis 168. The overexpression plasmid map is shown in the figure. Figure 1 As shown, the obtained recombinant strain was named "SPO0A". The nucleotide sequence of spo0A is as follows: GTGGAGAAAATTAAAGTTTGTGTTGCTGATGATAATCGAGAGCTGGTAAGCCTGTTAAGTGAATATATAGAAGGACAGGAAGACATGGAAGTGATCGGCGTTGCTTATAACGGACAGGAATGCCTGTCGCTGTTTAAAGAAAAAGATCCCGATGTGCTCGTATTAGATATTATTATGCCGCATCTAGACGGACTTGCGGTTTTAGAGAGGCTGAGGGAATCAGATCTGAAAAAACAGCCGAATGTCATTATGCTGACAGCCTTTGGGCAGGAAGATGTCACGAAAAAGGCCGTCGATTTAGGCGCGTCCTACTTTATTCTCAAACCGTTTGATATGGAAAACCTTGTCGGCCATATCCGCCAGGTCAGCGGAAATGCCAGCAGTGTGACGCATCGTGCGCCATCATCGCAAAGCAGTATTATACGCAGCAGCCAGCCTGAACCAAAGAAGAAAAATCTCGACGCGAGCATCACAAGCATTATCCATGAAATCGGCGTCCCAGCCCATATTAAAGGCTATCTCTATCTGCGCGAAGCAATCTCAATGGTATACAATGACATCGAATTGCTCGGCAGCATTACAAAAGTCCTCTATCCGGACATCGCCAAAAAATTTAACACAACCGCAAGCCGTGTAGAAAGAGCGATCCGCCATGCAATTGAAGTGGCATGGAGCAGAGGAAACATTGATTCCATTTCCTCGTTGTTTGGTTATACTGTCAGCATGACAAAAGCTAAACCTACCAACAGTGAATTCATTGCAATGGTTGCGGATAAGCTGAGGTTAGAGCATAAGGCTTCTTAA (SEQ ID NO:1).

[0021] The control strain used in this example was obtained by expressing the empty plasmid pMA5 in the wild-type Bacillus subtilis 168, named "CON".

[0022] Preparation of bacterial solution: Use a 10 µL pipette tip to take a small amount of wild-type Bacillus subtilis and recombinant strain of Bacillus subtilis stored at -80°C in a glycerol tube, inoculate them into two 5 mL LB culture media, respectively, and culture at 37°C and 200 rpm in a shaking incubator for 12 h.

[0023] At 0 h, 12 h, 24 h, 36 h, 48 h, 60 h, and 72 h of fermentation, the residual glucose concentration and OD in the fermentation broth of the control strain (CON) and the overexpression strain (SPO0A) were measured respectively. 600 The glucose concentration was measured by DNS method, and the OD 600 The concentration of DPA was measured by high performance liquid chromatography (UV detector, detection wavelength of 270 nm, column temperature of 32°C). Figure 2 Glucose concentration and OD during fermentation of control strain (CON) and overexpression strain (SPO0A) 600 And the concentration of 2,6-pyridinedicarboxylic acid changes with time, according to Figure 2 It can be found that during the fermentation process, compared with CON, the glucose consumption rate and cell growth rate of SPO0A fermentation increased, and the DPA production increased. Example 2

[0024] Preventive effects of control strains and overexpression strains on sweet potato black spot Preparation of bacterial solution: Use the tip of a 10 μL pipette to take a small amount of the control strain (CON) and the overexpression strain (SPO0A) stored in a glycerol tube at -80°C, and inoculate them into two 50 mL LB medium, respectively, and culture them at 37°C, 200 rpm in a shaking incubator for 20 h. Add three pieces of sweet potato long-beaked shell fungus cakes to a bottle of 40 mL barley honey medium and culture them at 28°C, 200 rpm in a shaking incubator for 20 h, then discard the barley grains in the medium and keep the bacterial solution. The formula of barley honey medium is shown in Table 1.

[0025] Table 1 Barley honey culture medium formula (40 mL) Reagents quality Honey 0.6 g barley 0.1 g Peptone 0.2 g Distilled water Make up to 40 mL Centrifuge the three bacterial cultures at 4°C, 8,000 rpm for 10 min and discard the supernatant. 2 Resuspend the cell pellets obtained after centrifugation of the three bacterial solutions in 1% ddHO and centrifuge at 8,000 rpm for 5 min at 4°C. Discard the supernatant and retain the bacterial cells. Repeat this step twice. 2 Resuspend the CON and SPO0A cell pellets in 1 mL ddHO. 2 Resuspend the cell pellet of Echinops spp.

[0026] 60 sweet potato balls with a diameter of about 10 cm were cut and a small hole with a diameter of 2 mm and a depth of 5 mm was pierced on the surface of each sweet potato ball. The cells were divided into three groups and parallel experiments were performed. 20 sweet potato balls were sprayed with 10 mL CON cell resuspension; 20 sweet potato balls were sprayed with 10 mL SPO0A cell resuspension; 20 sweet potato balls were sprayed with 10 mL ddH 2 O. After standing at room temperature and drying, 10 μL of the fungus solution of sweet potato long beak shell was added to each small hole. After culturing in a constant temperature incubator at 28°C for 96 h, the diameter of the lesion plaque caused by the sweet potato long beak shell shell on each sweet potato round block was measured.

[0027] Observe the pathological changes of each group of sweet potato balls and select one group to take pictures. The results are as follows: Figure 3 As shown. Figure 3 It can be found that the diameter of the sweet potato lesions on the sweet potato discs sprayed with CON and SPO0A bacterial suspensions was significantly smaller than that on the discs sprayed with ddH 2 The diameter of the sweet potato lesions on the sweet potato blocks sprayed with O (control) and the sweet potato lesions on the sweet potato blocks sprayed with SPO0A resuspension were smaller than those on the sweet potato blocks sprayed with CON bacterial resuspension, indicating that CON and SPO0A can prevent sweet potato black spot disease, and the prevention effect of SPO0A on sweet potato black spot disease is better than CON.

Claims

1. A genetically engineered strain of Bacillus subtilis with improved 2,6-pyridinedicarboxylic acid production. It is characterized in that The genetically engineered bacteria is a bacterium that transfers the transcriptional regulatory factor spo0A into Bacillus subtilis ( Bacillus subtilis ) 168, the nucleotide sequence of the transcription regulatory factor spo0A is shown in SEQ ID NO:

1.

2. The method for preparing the genetically engineered bacteria according to claim 1, It is characterized in that The following steps are involved: Step 1, inserting the gene sequence of the transcriptional regulatory factor spo0A into the expression plasmid to obtain a recombinant plasmid; Step 2, transforming the recombinant plasmid obtained in step 1 into Bacillus subtilis ( Bacillus subtilis )168 obtained.

3. The preparation method according to claim 2, It is characterized in that The expression plasmid described in step 1 is pMA5.

4. Use of the genetically engineered bacteria according to claim 1 in the fermentation production of 2,6-pyridinedicarboxylic acid.

5. A product for preventing and controlling sweet potato black spot disease, It is characterized in that The active ingredients include the genetically engineered bacteria according to claim 1 after fermentation.